![]() Health Guide Drug Guide john's wortWhat is it?St. John's Wort is an herbal medicine used to treat mild to moderate depression, anxiety, seasonal affective disorder, premenstrual syndrome, and infection. It is also used to increase memory and concentration. St. John's Wort can be used on the skin to help heal wounds, control pain, and treat menopause symptoms. Other names for St. John's Wort include: Hypericum perforatum Ask your doctor, nurse, or pharmacist if you need more information about this medicine or if any information in this leaflet concerns you. Before Using:Tell your doctor if you ...
Dosage:Talk with your doctor, pharmacist, or nurse about how much St. John's Wort you should take. The amount depends on the strength of the medicine and the reason you are taking St. John's Wort. If you are using this medicine without instructions from your caregiver, follow the directions on the label. Do not take more St. John's Wort or take it more often than what is written on the directions. To store this medicine:Keep all medicine locked up and away from children. Store medicine away from heat and direct light. Do not store your medicine in the bathroom, near the kitchen sink, or in other damp places. Heat or moisture may cause the medicine to break down and not work the way it should work. Throw away medicine that is out of date or that you do not need. Never share your medicine with others. Drug and Food Interactions:Do not take St. John's Wort without talking to your doctor first if you are taking:
Warnings:
Side Effects:Stop taking your medicine right away and talk to your doctor if you have any of the following side effects.
Other Side Effects:You may have the following side effects, but this medicine may also cause other side effects. Tell your doctor if you have side effects that you think are caused by this medicine.
References:1. Vorbach EU, Huebner WD & Arnoldt KH: Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study to 135 outpatients. J Geriatr Psychiatry Neurol 1994; 7 Suppl 1: S19-S23. 2. Peebles KA, Baker RA, Kurz EU et al: Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrome from St. John's Wort (Hypericum perforatum). Biochem Pharmacol 2001; 62(8):1059-1070. 3. Mueller WE & Schaefer C: Johanniskraut. In vitro Studie ueber Hypericum-Extrakt, Hypericin, und Kaempferol als Antidepressiva. DAZ 1996; 136: 1015-1022. 4. Fachinformation Hyperimerck 260mg(R), hypericum extract. Merck Generika GmbH, Darmstadt, Germany; 1997. 5. Roots T: Evaluation of photosensitization of the skin and multiple dose intake of Hypericum extract. Second International Congress on Phytomedicine. Munich, Germany; 1996. 6. Woelk H, Burkard G & Gruenwald J: Benefits and risks of the Hypericum extract LI 160: drug monitoring with 3250 patients. J Geriatric Psychiatry Neurol 1994; 7 (Suppl 1):34-38. 7. Piscitelli SC, Burstein AH, Chaitt D et al: Indinavir concentrations and St. John's Wort. Lancet 2000; 355. 8. Fachinformation: Helarium(R) Hypericum, hypericum extract. Bionorica GmbH, Neumarkt, Germany; 1996. 9. Fachinformation: Remotiv(R), hypericum extract. Bayer AG, Pharma Deutschland, Leverkusen, Germany; 1996. 10. Ruschitzka F, Meier P, Turina M et al: Acute heart transplant rejection due to St. John's Wort. Lancet 2000; 355:548-549. 11. Gorski J, Hamman M, Wang Z et al: The effect of St. John's Wort on the efficacy of oral contraception (abstract MPI-80). Clin Pharmacol Ther 2002; 71(2):P25 12. Ernst E: Second thoughts about safety of St. John's Wort. Lancet 1999; 354(9195):2014-2015. 13. Brockmoller J, Reum T, Bauer S et al: Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiat 1997; 30(suppl):94-101. 14. Anon: St. John's Wort: drug interactions and safety. Alt Med Alert 2000; 3(6):71-72. 15. Khawaja IS, Marotta RF & Lippmann S: Herbal medicines as a factor in delirium (letter). Psychiatr Serv 1999; 50(7):969-970. 16. Beckman SE, Sommi RW & Switzer J: Consumer use of St. John's Wort: A survey on effectiveness, safety, and tolerability. Pharmacotherapy 2000; 20(5):568-574. 17. Roots I, Johne A, Schmider J et al: Interaction of a herbal extract from St. John's Wort with amitriptyline and its metabolites (abstract). Clin Pharmacol Ther 2000; 67(2):159. 18. DeMott K: St John's Wort tied to serotonin syndrome. Clin Psychiatry 1998; 26:28. 19. Jokovljevic V, Popovic M, Mimica-Dukic N et al: Pharmacodynamic study of Hypericum perforatum L. Phytomedicine 2000; 7(6):449-453. 20. Anon: Risk of drug interactions with St. John's Wort. JAMA 2000; 283(13):1679. 21. Nebel A, Schneider BJ, Baker RK et al: Potential metabolic interaction between St. John's Wort and theophylline. Ann Pharmacother 1999; 33(4):502. 22. Lantz M, Buchalter E & Giambanco V: St. John's Wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol 1999; 12(1):7-10. 23. De Maat MMR, Hoetelmans RMW, Mathot RAA et al: Drug interaction between St. John's Wort and nevirapine. AIDS 2001; 15(3):420-421. 24. Wonnemann M, Singer A & Muller WE: Inhibition of synaptosomal uptake of H-L-glutamate and H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology 2000; 23(2):188-197. 25. Sugimoto K, Ohmori M, Tsuruoka S et al: Different effects of St. John's Wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 2001; 70(6):518-524. 26. Prost N, Tichadou L, Rodor F et al: Interaction millepertuis-venlafaxine (article in French). Presse Med 2000; 29:1285-1286. 27. Barbanel DM, Yusufi B, O'Shea D et al: Mania in a patient receiving testosterone replacement post-orchidectomy taking St. John's Wort and sertraline. J Psychopharmacol 2000; 14:84-86. 28. Burstein AH, Horton RL, Dunn T et al: Lack of effect of St. John's Wort on carbamazepine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 2000; 68(6):605-612. 29. Yue QY, Bergquist C & Gerden B: Safety of St. John's Wort. Lancet 2000; 355:576-577. 30. Maurer A, Johne A, Bauer S et al: Interaction of St. John's wort extract with phenprocoumon (abstract). Eur J Clin Pharmacol 1999; 55:A22. 31. Bolley R, Zulke C, Kammerl M et al: Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St. John's Wort. Transplantation 2002; 73(6):1009. 32. Mathijssen RHJ, Verweij J, DeBruijn P et al: Effects of St. John's Wort on irinotecan metabolism. J Natl Cancer Inst 2002; 94(16):1247-1249. 33. Wang Z, Gorski JC, Hamman MA et al: The effects of St. John's Wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001; 70(4):317-326. 34. Patel S, Robinson R & Burk M: Hypertensive crisis associated with St. John's Wort. Am J Med 2002; 112(6):507-508. 35. Stevinson C & Ernst E: A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome. Br J Obstet Gynaecol 2000; 107(7):870-876. 36. Wheatley D: Hypericum in seasonal affective disorder (SAD). Curr Med Res Opin 1999; 15(1):33-37. 37. Martinez B, Kasper S, Ruhrmann S et al: Hypericum in the treatment of seasonal affective disorders. J Geriat Psych Neurol 1994; 7(1):29-33. 38. Vorbach EU, Arnold KH & Hubner WD: Efficacy and tolerability of St. John's Wort extract hypericum extract LI 160 in patients with severe depressive incidents according to ICD-10. Pharmacopsychiatry 1997; 30 (suppl 1):S81-S85. 39. Hypericum Depression Trial Study Group: Effect of hypericum perforatum (St. John's Wort) in major depressive disorder. JAMA 2002; 287(14):1807-1814. 40. Gurley BJ, Gardner SF, Hubbard MA et al: Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 2002; 72(3):276-287. 41. Dannawi M: Possible serotonin syndrome after combination of buspirone and St. John's Wort. J Psychopharmacol 2002; 16(4):401. 42. Eich-Hochli D, Oppliger R, Golay KP et al: Methadone maintenance treatment and St. John's Wort. Pharmacopsychiatry 2003;36(1):35-37. 43. Irefin S & Sprung J: A possible cause of cardiovascular collapse during anesthesia: Long-term use of St. John's Wort. J CLin Anesth 2000; 12:498-499. 44. Product Information: Soriatane(R), acitretin. Roche Laboratores, Inc, Nutley, NJ; 2003. 45. Product Information: Gleevec(TM), imatinib mesylate. Novartis Pharmaceuticals, East Hanover, NJ; 2003. 46. Ladner DP, Klein SD, Steiner RA et al: Synergistic toxicity of delta-aminolaevulinic acid-induced protoporphyrin IX used for photodiagnosis and hypericum extract, a herbal antidepressant. Br J Dermatol 2001; 144(4):916-918. 47. Upton R (ed): St. John's Wort, Hypericum perforatum: quality control, analytical and therapeutic monograph. Am Herbal Pharmacopoeia, Santa Cruz, CA; 1997. 48. Hussain MD: Saint John's Wort and analgesia: Effect of St. John's Wort on morphine induced analgesia. AAPS Pharm Sci 2000; 2(2):Abstract 1810. 49. Product Information: Cordarone(R), amiodarone. Wyeth Laboratories, Philadelphia, PA (PI revised 08/2001), reviewed 12/2003. 50. Hebert MF, Park JM, Chen Y-L et al: Effects of St. John's Wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol 2004; 44:89-94. 51. Wang L-S, Zhou G, Zhu B et al: St Johns wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther 2004; 75(3):191-197. 52. Frye RF, Fitzgerald SM, Lagattuta TF et al: Effect of St. John's Wort on imatinib mesylate pharmacokinetics. Abstract PDII-B-4. Clin Pharmacol Ther 2004; 75(2):96. Last Updated: 4/4/2008 Copyright © 1984-2007 Thomson Micromedex. All rights reserved. |
|